Publication | Open Access
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
128
Citations
38
References
2011
Year
Some patients who had limited tumor burden with minimal prior chemotherapy seemed to benefit from the vaccine. Further studies to confirm these results are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1